Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Dr. Martens Plc ( (GB:DOCS) ) has provided an update.
Dr. Martens plc has announced that its total issued ordinary share capital consists of 966,315,401 shares, each with a voting right, and none held in Treasury. This information is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:DOCS) stock is a Hold with a £0.85 price target. To see the full list of analyst forecasts on Dr. Martens Plc stock, see the GB:DOCS Stock Forecast page.
Spark’s Take on GB:DOCS Stock
According to Spark, TipRanks’ AI Analyst, GB:DOCS is a Neutral.
Dr. Martens Plc scores a 67, reflecting a balance of mixed financial performance, challenging technical indicators, and reasonable valuation. The company’s strong cash flow and strategic corporate events provide optimism, though declining revenue and weak technical signals pose concerns. The recent corporate events bolster stakeholder confidence, contributing to a moderately positive outlook.
To see Spark’s full report on GB:DOCS stock, click here.
More about Dr. Martens Plc
Dr. Martens plc is a prominent company in the footwear industry, known for its iconic boots and shoes. The company focuses on producing durable and fashionable footwear that appeals to a wide range of consumers globally.
Average Trading Volume: 1,607,658
Technical Sentiment Signal: Buy
Current Market Cap: £738M
See more data about DOCS stock on TipRanks’ Stock Analysis page.